En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Expo: Clinical Laboratory

Blood/Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Other

Browse Products by Category

Close

ORTHO CLINICAL DIAGNOSTICS

ORTHO CLINICAL DIAGNOSTICS

Ortho Clinical Diagnostics is a global provider of in vitro diagnostics, including testing platforms and clinical assay tests to monitor disease progression across multiple disease categories such as infectious diseases, cardiology and endocrinology. It also offers laboratory systems and blood typing products in immunohematolog ...
Products Covid-19NewsSummary
Close

Covid-19 ORTHO CLINICAL DIAGNOSTICS

Clinical Laboratory

Anti-SARS-CoV-2 IgG QN Antibody Assay
VITROS Anti-SARS-CoV-2 IgG QN Antibody Assay

The VITROS Anti-SARS-CoV-2 IgG QN Antibody assay is intended for the qualitative detection and quantitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma and is processed on Ortho's trusted VITROS system. With 100% specificity and excellent sensitivity, the assay provides numerical values traceable to the World Health Organization (WHO) International Standard, which helps standardize SARS-CoV-2 serological methods and allows for unified data comparison across laboratories.
More details

Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test
VITROS Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test

The VITROS Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test is a highly accurate4 test for the qualitative detection of SARS-CoV-2 nucleocapsid antibodies in patients who have been infected with the SARS-CoV-2 virus. The test helps health care teams differentiate the cause of antibodies against SARS-CoV-2 and is processed on Ortho's VITROS Systems.
More details

SARS-CoV-2 Antigen Test
VITROS SARS-CoV-2 Antigen Test

The VITROS SARS-CoV-2 Antigen Test is a laboratory immunoassay for the in-vitro qualitative detection of the SARS-CoV-2 nucleocapsid antigen that delivers fast, high-volume testing for active infection with excellent specificity and sensitivity, making it a viable alternative to PCR testing. Results are reported as either reactive (positive) or non-reactive (negative) with no gray zone, providing healthcare systems and communities more capacity to quickly and accurately diagnose individuals with an active infection. The VITROS SARS-CoV-2 Antigen Test is fully compatible with Ortho’s VITROS XT 7600 and 5600 Integrated Systems and VITROS 3600 Immunodiagnostic System.
More details

SARS-CoV-2 (COVID-19) Antibody Test
40) VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack

The VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack detects antibodies (including IgG and IgM) to SARS-CoV-2 that can be used to detect immune response to the virus. The test can be used in epidemiological research to help better understand the spread of the disease and can also be used to aid in the diagnosis of suspected COVID-19 patients in conjunction with molecular tests. The test will run on Ortho’s flagship analyzer, the VITROS XT 7600 Integrated System, the VITROS 3600 Immunodiagnostic System, the VITROS 5600 Integrated System and VITROS ECi/ECiQ Immunodiagnostic Systems and can process approximately 150 tests in an hour. The test has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) and has also received CE Mark.
More details

SARS-CoV-2 (COVID-19) Antibody Test
VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test

The VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test is a COVID-19 IgG antibody test that detects the IgG antibody and offers 100% specificity. It offers greater choice in tracking and surveillance, patient management, and screening convalescent plasma. The test has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) and runs on Ortho's high-throughput, fully automated analyzers including its flagship VITROS XT 7600 Integrated System, the VITROS 3600 Immunodiagnostic System, and the VITROS 5600 Integrated System.
More details
Close

News of ORTHO CLINICAL DIAGNOSTICS

QuidelOrtho Formed by Combining Quidel and Ortho

31 May 2022
QuidelOrtho Formed by Combining Quidel and Ortho
QuidelOrtho Corporation (San Diego, CA, USA) has announced the completion of the transaction combining Quidel Corporation (San Diego, CA, USA) and Ortho Clinical Diagnostics (Raritan, NJ, USA), creating QuidelOrtho, a leading in vitro diagnostics company.
Read More

Ortho y Thermo Fisher hacen una sociedad para la comercialización de productos de control de calidad

24 Aug 2021
Ortho y Thermo Fisher hacen una sociedad para la comercialización de productos de control de calidad
Ortho Clinical Diagnostics (Raritan, NJ, EUA) firmó un acuerdo de distribución con Thermo Fisher Scientific Inc. (Waltham, MA, EUA) para proporcionar y respaldar los controles de calidad MAS y el software de garantía de calidad LabLink xL a través de las soluciones VITROS QC de Ortho para los clientes del sistema VITROS todo el mundo.
Read More

Ortho and Thermo Fisher Enter Into Partnership for Quality Control Products

08 Jul 2021
Ortho and Thermo Fisher Enter Into Partnership for Quality Control Products
Ortho Clinical Diagnostics (Raritan, NJ, USA) has entered into a distribution agreement with Thermo Fisher Scientific Inc. (Waltham, MA, USA) to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's VITROS QC Solutions to VITROS System customers worldwide.
Read More

Ortho Clinical Diagnostics presenta avances cardíacos en EuroMedLab 2019

28 May 2019
Ortho Clinical Diagnostics presenta avances cardíacos en EuroMedLab 2019
Ortho Clinical Diagnostics (Raritan, NJ, EUA) patrocinó un taller educativo sobre los ensayos de troponina de alta sensibilidad y presentó cinco pósteres científicos en EuroMedLab 2019, durante el 23º Congreso Europeo de Química Clínica y Medicina de Laboratorio IFCC-EFLM, que se realizó del 19 al 23 de mayo de 2019 en el CCIB -Centro de Convenciones Internacional de Barcelona. Ortho también mostró sus nuevas láminas de productos químicos VITROS, la Celda VITROS, una solución de automatización compacta que permite que dos instrumentos VITROS XT 7600 (lanzados en 2018) funcionen como una solución perfecta, y el Sistema Integrado VITROS XT 7600 en su stand durante el Congreso. 
Read More

Ortho Clinical Diagnostics Presents Cardiac Advances at EuroMedLab 2019

20 May 2019
Ortho Clinical Diagnostics Presents Cardiac Advances at EuroMedLab 2019
Ortho Clinical Diagnostics sponsored an educational workshop on high-sensitivity troponin assays and presented five scientific posters at EuroMedLab 2019, the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place from May 19-23, 2019, at the CCIB - Centre Convencions Internacional in Barcelona.
Read More

Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay

17 Oct 2017
Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay
Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB) assay, an important marker used in conjunction with clinical findings and other lab tests for the diagnosis and management of ketoacidosis and its main causative factor, diabetic ketoacidosis (DKA). The fully automated assay is now available for use on Ortho's VITROS 4600 chemistry system and the VITROS 5600 integrated system.
Read More
Close

About ORTHO CLINICAL DIAGNOSTICS

Ortho Clinical Diagnostics is a global provider of in vitro diagnostics, including testing platforms and clinical assay tests to monitor disease progression across multiple disease categories such as infectious diseases, cardiology and endocrinology. It also offers laboratory systems and blood typing products in immunohematology to hospitals, hospital networks, blood banks, and labs around the world.

Recently updated

Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test
VITROS Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test

The VITROS Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test is a highly accurate4 test for the qualitative detection of SARS-CoV-2 nucleocapsid antibodies in patients who have been infected with the SARS-CoV-2 virus. The test helps health care teams differentiate the cause of antibodies against SARS-CoV-2 and is processed on Ortho's VITROS Systems.
More details

Anti-SARS-CoV-2 IgG QN Antibody Assay
VITROS Anti-SARS-CoV-2 IgG QN Antibody Assay

The VITROS Anti-SARS-CoV-2 IgG QN Antibody assay is intended for the qualitative detection and quantitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma and is processed on Ortho's trusted VITROS system. With 100% specificity and excellent sensitivity, the assay provides numerical values traceable to the World Health Organization (WHO) International Standard, which helps standardize SARS-CoV-2 serological methods and allows for unified data comparison across laboratories.
More details

SARS-CoV-2 Antigen Test
VITROS SARS-CoV-2 Antigen Test

The VITROS SARS-CoV-2 Antigen Test is a laboratory immunoassay for the in-vitro qualitative detection of the SARS-CoV-2 nucleocapsid antigen that delivers fast, high-volume testing for active infection with excellent specificity and sensitivity, making it a viable alternative to PCR testing. Results are reported as either reactive (positive) or non-reactive (negative) with no gray zone, providing healthcare systems and communities more capacity to quickly and accurately diagnose individuals with an active infection. The VITROS SARS-CoV-2 Antigen Test is fully compatible with Ortho’s VITROS XT 7600 and 5600 Integrated Systems and VITROS 3600 Immunodiagnostic System.
More details

Clinical Laboratory

Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test
VITROS Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test

The VITROS Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test is a highly accurate4 test for the qualitative detection of SARS-CoV-2 nucleocapsid antibodies in patients who have been infected with the SARS-CoV-2 virus. The test helps health care teams differentiate the cause of antibodies against SARS-CoV-2 and is processed on Ortho's VITROS Systems.
More details

Anti-SARS-CoV-2 IgG QN Antibody Assay
VITROS Anti-SARS-CoV-2 IgG QN Antibody Assay

The VITROS Anti-SARS-CoV-2 IgG QN Antibody assay is intended for the qualitative detection and quantitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma and is processed on Ortho's trusted VITROS system. With 100% specificity and excellent sensitivity, the assay provides numerical values traceable to the World Health Organization (WHO) International Standard, which helps standardize SARS-CoV-2 serological methods and allows for unified data comparison across laboratories.
More details

SARS-CoV-2 Antigen Test
VITROS SARS-CoV-2 Antigen Test

The VITROS SARS-CoV-2 Antigen Test is a laboratory immunoassay for the in-vitro qualitative detection of the SARS-CoV-2 nucleocapsid antigen that delivers fast, high-volume testing for active infection with excellent specificity and sensitivity, making it a viable alternative to PCR testing. Results are reported as either reactive (positive) or non-reactive (negative) with no gray zone, providing healthcare systems and communities more capacity to quickly and accurately diagnose individuals with an active infection. The VITROS SARS-CoV-2 Antigen Test is fully compatible with Ortho’s VITROS XT 7600 and 5600 Integrated Systems and VITROS 3600 Immunodiagnostic System.
More details

SARS-CoV-2 (COVID-19) Antibody Test
VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test

The VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test is a COVID-19 IgG antibody test that detects the IgG antibody and offers 100% specificity. It offers greater choice in tracking and surveillance, patient management, and screening convalescent plasma. The test has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) and runs on Ortho's high-throughput, fully automated analyzers including its flagship VITROS XT 7600 Integrated System, the VITROS 3600 Immunodiagnostic System, and the VITROS 5600 Integrated System.
More details

SARS-CoV-2 (COVID-19) Antibody Test
40) VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack

The VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack detects antibodies (including IgG and IgM) to SARS-CoV-2 that can be used to detect immune response to the virus. The test can be used in epidemiological research to help better understand the spread of the disease and can also be used to aid in the diagnosis of suspected COVID-19 patients in conjunction with molecular tests. The test will run on Ortho’s flagship analyzer, the VITROS XT 7600 Integrated System, the VITROS 3600 Immunodiagnostic System, the VITROS 5600 Integrated System and VITROS ECi/ECiQ Immunodiagnostic Systems and can process approximately 150 tests in an hour. The test has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) and has also received CE Mark.
More details

Chemistry System
VITROS XT 3400

The VITROS XT 3400 Chemistry System simultaneously performs two tests frequently ordered together on one VITROS XT MicroSlide and offers up to 40% higher throughput than current slides. Its double assay processing offers a 25% faster turnaround time on a common panel of assays with an average processing time of 7.5 minutes and allows for the lowest sample volume at 2.7μl.
More details

Integrated Chemistry System
VITROS XT Solutions

VITROS XT Solutions, which include the new VITROS XT 3400 Chemistry System and the VITROS XT 7600 Integrated System with new XT MicroSlides, help ensure the right result the first time, with an industry-leading 96.5% first-pass yield. They reduce the need for manual interventions such as those caused by reviews, reruns or redraws by 75% as compared to competitive systems and provides up to 300 more tests per day without delay for labs doing one million tests annually.
More details

HIV Assay
VITROS HIV Combo

The VITROS HIV Combo is a fourth generation assay for early detection as it tests for a combination of antibodies: HIV-1, HIV-2, as well as the HIV p24 antigen. With class-leading p24 antigen sensitivity that doesn't sacrifice specificity, it gives the utmost confidence in results.
More details

Lab Middleware
ORTHO CONNECT

The ORTHO CONNECT is a middleware solution that acts as a link between ORTHO instruments and the lab information system (LIS), bringing everything to the user’s fingertips to help streamline operations and maximize resources. Acting as an intermediary, it allows the systems to exchange data, perform data management and complete regulatory process tasks that neither can easily perform alone.
More details

Automated Pipetting & Processing System
ORTHO VIP

The ORTHO VERSEIA Integrated Processor (VIP) is an automated pipetting and processing system that brings together the ORTHO VERSEIA Pipetter and ORTHO Summit Processor to enable end-to-end pipetting and processing. It enables automated scheduling and upfront loading capacity of 544 samples, reagents, and consumables—for six hours of operator walk-away time, and also offers 22 hours of continuous processing ability.
More details

Immunoassays
VITROS Assays Menu

The VITROS 5600 System broad menu of quality assays covers 90% of the menu needs and 99% of the testing volume for typical labs, providing actionable diagnostic insights that provide medical value for health care professionals. The 120 state-of-the-art assays immunoassays span all major disease categories, including chemistry, proteins, oncology, infectious diseases, anemia, cardiology and 20 user-defined chemistry channels.
More details

Immunoassay Analyzer
ASTUTE140 Meter

The ASTUTE140 Meter is an in vitro diagnostic platform that uses a sandwich immunoassay technique along with fluorescence detection technology to quantitatively measure novel biomarker concentrations of acute medical conditions and displays the test results on its LCD screen. Multiple quality control procedures ensure accurate results, which can then be printed or sent electronically to the laboratory information system (LIS).
More details

AKI Biomarker Assay
NEPHROCHECK Test

The NEPHROCHECK Test is a single-use cartridge designed for use on the VITROS line of automated, high-volume testing platforms to detect biomarkers of moderate to severe Acute Kidney Injury risk (AKI). It tests for two novel biomarkers (TIMP-2 and IGFBP-7) involved in G1 cell cycle arrest during the very early phases of cellular stress and are robust measures of moderate to severe risk for AKI manifesting within the next 12–24 hours.
More details

Integrated System
VITROS XT 7600

The VITROS XT 7600 integrated system combines Ortho's proprietary dry slide technology with sophisticated digital imaging capabilities and the potential to perform two separate lab tests simultaneously. It delivers even more enhanced, high-quality test results, higher throughput and an improved patient experience, all within the lab's existing physical footprint.
More details

Risk Assessment Tool
VITROS NephroCheck

The VITROS NephroCheck test is the first fully automated risk assessment tool for predicting Acute Kidney Injury (AKI). The simple urine test has received CE Mark clearance, provides lab results in 16 minutes, and can run on VITROS 3600/5600 immunodiagnostic systems.
More details

Chemistry Analyzer
VITROS 350

The VITROS 350 is a compact chemistry system with unique sample processing capabilities, including single-use disposable tips, bubble and clot detection. It helps achieve fewer repeats, redraws, and dilutions than with traditional liquid systems, and is designed to be efficient, dependable, and easy to use as a primary, STAT, or backup system.
More details

Blood Testing System
ORTHO Workstation

The ORTHO Workstation is the only compact 2-in-1 blood testing system with reliable ID-Micro Typing System (ID-MTS) Gel Column Agglutination Technology engineered to ensure accuracy. It uses proven reliable ID-MTS Gel Cards to offer clear, stable, well-defined end points, objective interpretation of results, and a full assay portfolio.
More details

Auto Hematology Analyzer
ORTHO VISION Max

The ORTHO VISION Max is a fully-automated blood analyzer for high-volume transfusion medicine laboratories and also supports more complex immunohematology testing such as serial dilutions for titration studies, reflex tests and selected cell antibody identification. Its flexibility and responsiveness allows processing of routine samples and STAT orders as they are received, making it ideal for labs conducting greater than 50 types and screens per day.
More details

Immunodiagnostic System
VITROS ECiQ

The VITROS ECiQ immunodiagnostic system verifies and documents each step throughout processing, reduces analytical errors, and provides real-time status on the quality of every patient result. It offers features such as unique short sample, clot, and bubble detection for greater security, while single-use disposable tips eliminate sample carryover and cross contamination.
More details

Immunoassay Analyzer
VITROS 3600

The VITROS 3600 System is built to handle peak testing workloads and maximize turnaround and system walk-away times, while reducing error potential and increasing result quality with self-monitoring VITROS technologies. It offers more than 40 world-class immunoassays across all the major disease states including cardiac, prenatal, infectious disease, oncology, anemia and more.
More details

Chemistry Analyzer
VITROS 4600

The VITROS 4600 Chemistry System eliminates carryover by using disposable, single-use tip design and improves result evaluation and trending ability within peer groups with configurable assay ranges that account for seven demographic attributes for greater specificity. It covers assays across a range of disease areas, including chemistry, metabolic, proteins, diabetes and immunosuppressants.
More details

Immunoassay Analyzer
VITROS 5600

The VITROS 5600 integrated system combines five proven technologies to remove obstacles for reducing turnaround time and providing meaningful results. Its broad menu of quality assays covers 90% of the menu needs and 99% of the testing volume for typical labs, with over 120 state-of-the-art assays across a broad range of disease areas.
More details

Hematology Analyzer
ORTHO VISION Analyzer

The ORTHO VISION Analyzer automates the full range of immunohematology testing including serial dilutions for titration studies and selected cell panels, which helps to eliminate manual testing, including specialty testing. Apart from an extensive menu of tests, it also provides responsive safety checks and balances to give blood bankers the ability to monitor every critical step in the automation process.
More details
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions